The relative increase in concentrations of CD4 + T cells and CD4 + helper T cells as well as CD8 + T cells in the tumor and peripheral blood following SPD (Fig. 3) is consistent with previous reports of increased concentrations of T cells in SPD-treated Renca xenografts [6]. Here, CD8A is linked to neoplasm.